Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v3-EN
Language French English
Date Updated 2021-10-06 2021-09-23
Drug Identification Number 02448602 02448602
Brand name TRULICITY TRULICITY
Common or Proper name DULAGLUTIDE DULAGLUTIDE
Company Name ELI LILLY CANADA INC ELI LILLY CANADA INC
Ingredients DULAGLUTIDE DULAGLUTIDE
Strength(s) 1.5MG 1.5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size 4 x 0.5 ml single-use prefilled pen 4 x 0.5 ml single-use prefilled pen
ATC code A10BJ A10BJ
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2021-10-07 2021-10-05
Actual start date
Estimated end date 2021-10-08
Actual end date 2021-10-06
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments Please contact Eli Lilly Canada's Response Centre 1-888-545-5972 should you have any questions (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays) Please contact Eli Lilly Canada's Response Centre 1-888-545-5972 should you have any questions (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays)
Health Canada comments